U.S. stocks were on pace to close out their best week in nearly two years on Friday, helped by earnings from Microsoft and Procter & Gamble and as concerns eased over the possible spread of Ebola.

AbbVie's Shire deal is dead; stocks perk up on Ebola treatment linkage

The best scoring ADRs from one year ago (9/30/2013) returned an average 11.03%, 4.91% better than the MSCI EAFE index EFA. The best performing from our list have been SHPG up 120%, TTM up 69%, and GGAL up 50%.

In this interview with The Life Sciences Report, Vernon Bernardino of MLV & Co. brings some clarity and perspective to investors who could reap windfalls from small-cap names in which shareholder value has yet to be created and realized.

Sangamo has the ability to improve HIV patient's lives with a new form of treatment